<DOC>
	<DOC>NCT02152358</DOC>
	<brief_summary>The aim of this study is to show that a preemptive treatment by ganciclovir (for positive CMV viremia) or aciclovir (for positive HSV oro-pharyngeal PCR) is able to increase the number of ventilator-free days at Day 60.</brief_summary>
	<brief_title>PTH - Preemptive Treatment for Herpesviridae</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Viral</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>mechanical ventilation &gt; 96 hrs and expected duration of mechanical ventilation of at least 2 days positive blood CMV PCR (500 IU/ml) OR positive oropharyngeal HSV PCR age &gt; 18 years informed consent negative pregnancy test &lt; 18 years Receiving ganciclovir or aciclovir or another antiviral agent active against HSV/CMV Had received antiviral agent active against HSV/CMV during the previous month Hypersensitivity to aciclovir/ganciclovir Pregnancy Breast feeding Bone marrow failure Solid organ recipients Bone marrow recipients HIV positive patients Receiving immunosuppressive agents SAPS II &gt; 75 Withdrawing/withholding Neutropenia (&lt; 500 mm3) Thrombocytopenia (&lt; 25 G/L) ICU readmission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cytomegalovirus</keyword>
	<keyword>Herpes simplex virus</keyword>
	<keyword>ICU</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>mortality</keyword>
	<keyword>ventilator-free days</keyword>
	<keyword>PCR</keyword>
</DOC>